Syra Health Corp. Class A Common Stock (SYRA) financials · rev $7.2M
Syra Health Corp. Class A Common Stock (SYRA) rev $7.2M.
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $7.2M | $8.0M | $5.5M |
| Cost of Revenue | $4.7M | $6.3M | $4.1M |
| Gross Profit | $2.5M | $1.7M | $1.4M |
| Operating Income | -$904.3K | -$3.8M | -$2.9M |
| Net Income | -$896.3K | -$3.8M | -$2.9M |
| EPS (Diluted) | $-0.08 | $-0.50 | $-0.60 |
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | $2.8M | $3.7M | $4.9M | $2.3M |
| Current Assets | $2.7M | $3.4M | $4.8M | $0 |
| Cash & Equivalents | $1.6M | $2.4M | $3.3M | $3.3K |
| Inventory | $0 | $0 | $0 | $0 |
| PP&E | $7.0K | $27.3K | $79.0K | $0 |
| Total Liabilities | $674.7K | $800.8K | $910.1K | $1.6M |
| Current Liabilities | $674.7K | $613.5K | $910.1K | $0 |
| Short-term Debt | $0 | $0 | $0 | $0 |
| Long-term Debt | $0 | $0 | $0 | $0 |
| Total Debt | $0 | $0 | $0 | $0 |
| Shareholders' Equity | $2.1M | $2.9M | $4.0M | $0 |
| Retained Earnings | -$9.7M | -$8.8M | -$5.1M | $0 |
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating Cash Flow | -$447.7K | -$2.9M | -$2.8M |
| CapEx | $107 | $11.1K | $15.3K |
| Investing Cash Flow | -$107 | -$11.1K | -$15.3K |
| Financing Cash Flow | -$332.8K | $2.1M | $6.1M |
| Dividends Paid | $0 | $0 | $0 |
| Net Change in Cash | -$780.7K | -$884.7K | $3.3M |
| Free Cash Flow | -$447.9K | -$2.9M | -$2.8M |
FAQ
What is SYRA P/E and revenue?
Syra Health Corp. Class A Common Stock (SYRA) rev $7.2M.
What is SYRA revenue?
Syra Health Corp. Class A Common Stock last cached revenue is $7.2M (FY2025).
Is SYRA profitable?
Syra Health Corp. Class A Common Stock last cached net income is -$896.3K.
What are SYRA total assets?
Syra Health Corp. Class A Common Stock last cached total assets are $2.8M.
What is SYRA free cash flow?
Syra Health Corp. Class A Common Stock last cached free cash flow is -$447.9K.
Not investment advice. Cached statements, not a live tape.